Effect of Triclosan-coated Suture on Superficial SSI
Phase 3
Completed
- Conditions
- Surgical Site Infection
- Registration Number
- NCT02018289
- Lead Sponsor
- Hospital General Universitario Elche
- Brief Summary
The abdominal closure with triclosan coated suture will reduce superficial surgical site infection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
- Fecal peritonitis
Exclusion Criteria
- Perioperative mortality
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Superficial surgical site infection (SSI) 60 postoperative days SSI will be evaluated in the postoperative course and up to 60 days after surgery
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain triclosan's antimicrobial efficacy in surgical sutures?
How does triclosan-coated suture compare to standard sutures in reducing superficial surgical site infections?
Are there specific biomarkers that predict response to triclosan-coated sutures in abdominal surgery?
What are the potential adverse events associated with triclosan-coated sutures and how are they managed?
What alternative antimicrobial agents or combination therapies are being explored for surgical site infection prevention?
Trial Locations
- Locations (1)
General University Hospital Elche
🇪🇸Elche, Alicante, Spain
General University Hospital Elche🇪🇸Elche, Alicante, Spain